When I searched for photos of 'InMode' here on Seeking Alpha to add as an image for this article, oddly, a bunch of images of toilets appeared. That just about summarizes InMode's performance recently. In November, I wrote an article on InMode (I objectively search for undervalued stocks of any size across a wide variety of industries using quantitative methods that I've thoroughly backtested for success. I believe the numbers are more important than the story (most of the time), as they tend to paint a mor ...

Conference call to be held on Thursday, February 6, 2025, at 8:30 a.m. Eastern Standard Time YOKNEAM, Israel, Jan. 8, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the fourth quarter and full year 2024 before the Nasdaq market opens on Thursday, February 6, 2025. InMode is currently finalizing its financial results for the fourth quarter and full year of 2024. Management beli ...

InMode Ltd. (NASDAQ: INMD ) reports impressive net income growth coming from the sale of non-invasive surgical products. The company recently delivered two more platforms, Define and Envision, which may bring further business growth in the future. In addition, the company'sLike the common kingfisher or Alcedo Atthis searches for small fish, I research small, and medium cap companies in Europe, the United States, and South America. You can find a common kingfisher in my profile.With close to 14 years in the ...

InMode (NASDAQ: INMD ) recently reported its Q3-2024 results, so it's time to revisit the stock. I last wrote about InMode on September 6 and called it an " inverse bubble caused by short-term I objectively search for undervalued stocks of any size across a wide variety of industries using quantitative methods that I've thoroughly backtested for success. I believe the numbers are more important than the story (most of the time), as they tend to paint a more realistic picture of the company's prospects. I ha ...

InMode’s (NASDAQ: INMD ) products are part of the medical aesthetics industry that is expected to grow at an 11% CAGR over the next five years. Despite a punishing macro environment of late that hasI have been investing in the stock market since I was 17 years old, and over the 25+ years since I have learned the joy of compounding, the value of dividend reinvesting, and the principle that patient investing through good times and bad brings the greatest rewards. I believe the key to creating wealth is the sl ...

InMode Ltd. (NASDAQ:INMD) Q3 2024 Earnings Conference Call October 30, 2024 8:30 AM ET Company Participants Miri Segal - CEO, MS-IR Moshe Mizrahy - Chief Executive Officer Michael Kreindel - Chief Technology Officer Yair Malca - Chief Financial Officer Eran Krieger - Medical Director and VP of Medical Affairs Rafael Lickerman - Vice President, Finance Conference Call Participants Matt Miksic - Barclays Caitlin Cronin - Canaccord Genuity Sam Eiber - BTIG Operator Good day, and welcome to the InMode's Third Q ...

InMode (INMD) came out with quarterly earnings of $0.70 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.61 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 22.81%. A quarter ago, it was expected that this maker of cosmetic surgery devices would post earnings of $0.30 per share when it actually produced earnings of $0.34, delivering a surprise of 13.33%. Over the last four quar ...

YOKNEAM, Israel, Oct. 30, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights: Quarterly GAAP revenue of $130.2 million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024). Quarterly revenues from consumables and service of $15.8 million, a decrease of ...

IRVINE, Calif., Oct. 24, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, has been granted a preliminary injunction by the U.S. District Court for the Central District of California in a lawsuit filed against sellers identified to be the source of unlawful counterfeit sales of Morpheus8 radiofrequency devices and cartridge accessories. InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofre ...

Wall Street expects a year-over-year decline in earnings on higher revenues when InMode (INMD) reports results for the quarter ended September 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on October 30, 2024, might help the stock move higher if these key numbers are better than expec ...